Join Prof. Carle Paul as he presents his selection of Editor’s Picks from the September 2026 issue of the JEADV:
- International consensus on dose reduction of biologics for patients with psoriasis: The DR. Delphi study by van Riel et al.
- Litifilimab efficacy on skin outcomes in cutaneous lupus erythematosus in the Phase 2 LILAC study by Werth et al.
- Durability of response to icotrokinra for high-impact site psoriasis: 1-year ICONIC-TOTAL findings by Warren et al.
- Role of comorbidities and medication on immunotherapy efficacy in cSCC: A DeCOG multicentre analysis by Geidel et al.
Article 1
Article 2
Article 3
Article 4
